Science Immunology -- Purchase Short-Term Access

Purchase Short-Term Access

IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer
Hubert et al. 2020 5 (46), p. eaav3942


Your receipt will be sent to this email address. If you have previously purchased access to content on this site, please enter the same email address so we can detect any duplicate purchases.

You may view, download, and/or print the article for your personal scholarly, research, and educational use. You may not (i) distribute a copy (electronic or otherwise) of the article without the written permission of AAAS, (ii) post the article on an electronic bulletin board or web site, or (iii) charge for a copy (electronic or otherwise) of the article.